Hiscox Ltd Stock London S.E.
Equities
BMG4593F1207
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.93B 6.71B | Sales 2025 * | 4.27B 5.41B 7.36B | Capitalization | 3.99B 5.06B 6.89B |
---|---|---|---|---|---|
Net income 2024 * | 470M 596M 811M | Net income 2025 * | 505M 640M 871M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
8.55
x | P/E ratio 2025 * |
7.85
x | Employees | - |
Yield 2024 * |
2.78% | Yield 2025 * |
3.08% | Free-Float | 92.33% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
1st Jan change | Capi. | |
---|---|---|
+39.59% | 62.16B | |
+16.46% | 52.72B | |
+12.53% | 49.83B | |
+18.78% | 44.62B | |
+31.78% | 36.61B | |
+10.91% | 29.51B | |
+49.51% | 28.42B | |
+27.04% | 25.57B | |
+15.32% | 21.39B |